Advanced search    

Search: authors:"J. R. de Groot"

12 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design

BackgroundTimely detection of atrial fibrillation (AF) in implantable cardioverter defibrillator (ICD) patients is clinically important for prevention of AF-related complications and inappropriate shocks. Patients with coronary artery disease (CAD) and a dual or triple chamber ICD show a high incidence of device-detected AF. Whether CAD patients with a single chamber ICD carry a...

The wearable defibrillator: a most affordable vest

Netherlands 1 J. R. de Groot - Published online: 13 April 2017 © The Author(s) 2017. This article is available at SpringerLink with Open Access. The implantable cardioverter-defibrillator (ICD) has become a

Can we spice up our Christmas dinner?

overwhelming (a recipe of Peking duck is provided in the online supplementary material under B). Conflict of interest J. R. de Groot is a consultant for AtriCure and Daichii Sankyo and has received a research

Do elderly patients benefit from implantable-cardioverter defibrillators?

J. R. de Groot 0 ) Heart Center, Department of Cardiology, Academic Medical Center/ University of Amsterdam , Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands - Sudden cardiac death resulting

Epicardial mapping and ablation of arrhythmias: is magnetic navigation the answer we have been waiting for?

J. R. de Groot 0 T. Deneke 0 0 T. Deneke Heart Center Bad Neustadt , Bad Neustad/Saale, Germany 1 ) Heart Center, Department of Cardiology, Academic Medical Center/University of Amsterdam

A wider scope on the treatment of atrial fibrillation

J. R. de Groot 0 ) Heart Center, Department of Cardiology, Academic Medical Center/University of Amsterdam , Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands - Atrial fibrillation (AF) is the

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze

W. R. Berger R. E. Knops J. R. de Groot 0 ) Heart Center, Department of Cardiology , Academisch Medisch Centrum, Meibergdreef 9, 1100 DD Amsterdam, the Netherlands Atrial fibrillation (AF) is the

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?

Implantable cardioverter defibrillators (ICDs) are an established therapy for the prevention of sudden cardiac death. Since the 1990s multiple primary and secondary prevention trials, such as AVID, MADIT-I and II and SCD-HeFT, have demonstrated a significant reduction in mortality in patients with ischaemic and non-ischaemic cardiomyopathy, especially in survivors of ventricular...

First experience with the wearable cardioverter defibrillator in the Netherlands

R. E. Knops K. M. Kooiman J. N. ten Sande J. R. de Groot A. A. M. Wilde The implantable cardioverter defibrillator (ICD) has significantly improved survival in patients with an increased risk of